Anti-CD3/Anti-CD28 Bead Stimulation Overcomes CD3 Unresponsiveness in Patients With Head and Neck Squamous Cell Carcinoma
Open Access
- 1 April 2000
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA Otolaryngology–Head & Neck Surgery
- Vol. 126 (4), 473-479
- https://doi.org/10.1001/archotol.126.4.473
Abstract
THE INDUCTION of a T-cell immune response by antigen-presenting cells (APCs) occurs in 3 distinct stages. Initially, a nonspecific adhesion occurs between an APC and a T cell; next, the antigen–major histocompatibility complex of the APC crosslinks with the T-cell receptor (TcR). The final step occurs when a second or costimulatory signal is delivered by the APC to the T cell, enhancing stimulation. At present, the best-characterized second signal occurs when the B7.1 or B7.2 ligand of the APC binds to the CD28 receptor of the T cell, resulting in enhanced cellular activation.1 The immune response initiated may be characterized as a type 1 (TH1) or 2 (TH2) response based on the cytokines secreted from CD4+ T cells. A TH1 response is characterized by the secretion of interleukin (IL)–2, tumor necrosis factor α (TNF-α), and interferon γ (IFN-γ) and represents a delayed hypersensitivity type of response or cytotoxic response against cancer or microbes. A TH2 response is characterized by the secretion of IL-4, IL-5, IL-6, IL-10, and IL-13 and enhances antibody production from B cells as well as an allergic response.2Keywords
This publication has 9 references indexed in Scilit:
- Immunotherapy for squamous cell carcinoma of the head and neckJapanese Journal of Clinical Oncology, 2020
- Anti-CD3/Anti-CD28 Monoclonal Antibody–Coated Suture Enhances the Immune Response of Patients With Head and Neck Squamous Cell CarcinomaJAMA Otolaryngology–Head & Neck Surgery, 1999
- Antiviral Effect and Ex Vivo CD4 + T Cell Proliferation in HIV-Positive Patients as a Result of CD28 CostimulationScience, 1996
- CTLA-4 can function as a negative regulator of T cell activationImmunity, 1994
- The B7 and CD28 receptor familiesImmunology Today, 1994
- Lipid-bound sialic acid, prostaglandin e and histamine in head and neck cancerEuropean Journal of Cancer, 1993
- Costimulation of T cells for tumor immunityImmunology Today, 1993
- T-cell antigen CD28 mediates adhesion with B cells by interacting with activation antigen B7/BB-1.Proceedings of the National Academy of Sciences of the United States of America, 1990
- CD28 activation pathway regulates the production of multiple T-cell-derived lymphokines/cytokines.Proceedings of the National Academy of Sciences of the United States of America, 1989